Zurich Cantonal Bank’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,030
| Closed | -$76K | – | 2954 |
|
|
2022
Q3 | $76K | Hold |
5,030
| – | – | ﹤0.01% | 2411 |
|
|
2022
Q2 | $38K | Hold |
5,030
| – | – | ﹤0.01% | 2671 |
|
|
2022
Q1 | $46K | Hold |
5,030
| – | – | ﹤0.01% | 2545 |
|
|
2021
Q4 | $35K | Hold |
5,030
| – | – | ﹤0.01% | 2808 |
|
|
2021
Q3 | $57K | Hold |
5,030
| – | – | ﹤0.01% | 2580 |
|
|
2021
Q2 | $81K | Hold |
5,030
| – | – | ﹤0.01% | 2304 |
|
|
2021
Q1 | $90K | Hold |
5,030
| – | – | ﹤0.01% | 2199 |
|
|
2020
Q4 | $68K | Hold |
5,030
| – | – | ﹤0.01% | 2349 |
|
|
2020
Q3 | $59K | Hold |
5,030
| – | – | ﹤0.01% | 2201 |
|
|
2020
Q2 | $74K | Buy |
5,030
+1,429
| +40% | +$21.1K | ﹤0.01% | 2083 |
|
|
2020
Q1 | $49K | Buy |
3,601
+1,351
| +60% | +$25.6K | ﹤0.01% | 1951 |
|
|
2019
Q4 | $54K | Hold |
2,250
| – | – | ﹤0.01% | 2104 |
|
|
2019
Q3 | $43K | Hold |
2,250
| – | – | ﹤0.01% | 2143 |
|
|
2019
Q2 | $66K | Hold |
2,250
| – | – | ﹤0.01% | 1888 |
|
|
2019
Q1 | $107K | Sell |
2,250
-503
| -18% | -$22.1K | ﹤0.01% | 1544 |
|
|
2018
Q4 | $99K | Buy |
2,753
+515
| +23% | +$24.2K | ﹤0.01% | 1606 |
|
|
2018
Q3 | $138K | Hold |
2,238
| – | – | ﹤0.01% | 1525 |
|
|
2018
Q2 | $151K | Buy |
2,238
+557
| +33% | +$31.2K | ﹤0.01% | 1411 |
|
|
2018
Q1 | $91K | Hold |
1,681
| – | – | ﹤0.01% | 1650 |
|
|
2017
Q4 | $100K | Buy |
1,681
+340
| +25% | +$20.6K | ﹤0.01% | 1566 |
|
|
2017
Q3 | $65K | Hold |
1,341
| – | – | ﹤0.01% | 1648 |
|
|
2017
Q2 | $70K | Buy |
1,341
+155
| +13% | +$7.22K | ﹤0.01% | 1567 |
|
|
2017
Q1 | $54K | Hold |
1,186
| – | – | ﹤0.01% | 1698 |
|
|
2016
Q4 | $45K | Buy |
1,186
+128
| +12% | +$4.84K | ﹤0.01% | 1768 |
|
|
2016
Q3 | $40K | Buy |
+1,058
| New | +$23.3K | ﹤0.01% | 1791 |
|
Zurich Cantonal Bank's AERI Position: Q4 2022 in Review
Zurich Cantonal Bank sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 5,030 shares — an estimated $76K sold.
Zurich Cantonal Bank first reported a position in AERI in Q3 2016 and held it in 25 quarters. The position peaked at $151K in Q2 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Zurich Cantonal Bank reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Zurich Cantonal Bank sold 5,030 Aerie Pharmaceuticals shares in Q4 2022, an estimated $76K.
- Zurich Cantonal Bank first reported a position in Aerie Pharmaceuticals in Q3 2016 and held it in 25 quarters.
- Zurich Cantonal Bank's Aerie Pharmaceuticals position peaked at $151K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Zurich Cantonal Bank's 13F filing for Q4 2022, filed 1 Feb 2023.